Skip to main content
    I

    Inogen Inc (INGN)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $5.63
    -0.06 (-1.05%)

    Market Cap: $147.95M

    Last updated: Nov 17, 2026 at 11:04 AM ET

    Inogen Inc (INGN) Financials: Revenue, Profit and Cash Flow

    Updated Nov 5, 2026. Financial statements from company filings, amounts in US dollars.

    Inogen reported revenue of $348.67M for the fiscal year ended Dec 31, 2025, up 3.9% from the year before. That year, net income was -$22.75M with a net margin of -6.5%, operating cash flow was -$11.22M and free cash flow was -$13.74M. The quarter ended Sep 30, 2026 had revenue of $77.19M and net income of -$16.16M.

    Revenue and Margins

    The operating margin was -8.7% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue grew from $202.83M, a compound annual rate of 6.2%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$348.67M+3.9%44.2%-8.7%-6.5%
    Dec 2024$335.70M+6.4%46.1%-12.7%-10.7%
    Dec 2023$315.66M-16.3%40.1%-34.7%-32.5%
    Dec 2022$377.24M+5.4%40.7%-22.6%-22.2%
    Dec 2021$358.00M+16.1%49.3%2.6%-1.8%
    Dec 2020$308.49M-57.4%44.8%-3.9%-1.9%
    Dec 2019$723.89M+34.9%23.7%2.7%2.9%
    Dec 2018$536.69M+115.2%66.5%7.1%9.7%
    Dec 2017$249.44M+23.0%48.6%11.1%8.4%
    Dec 2016$202.83MN/A48.0%11.3%10.1%
    Annual, fiscal years ended Dec 2016 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, the net loss narrowed from the year before. In the quarter ended Sep 2026, the net loss widened from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Revenue$348.67M$335.70M$315.66M$377.24M$358.00M$308.49M$723.89M$536.69M$249.44M$202.83M
    Cost of revenue$194.40M$180.96M$188.96M$223.71M$181.52M$170.31M$208.30M$179.53M$128.20M$105.52M
    Gross profit$154.26M$154.74M$126.70M$153.53M$176.48M$138.18M$171.86M$357.16M$121.24M$97.31M
    Research and development$19.40M$21.61M$20.84M$21.94M$16.58M$14.08M$9.40M$7.03M$5.31M$5.11M
    Operating income-$30.21M-$42.52M-$109.39M-$85.24M$9.24M-$12.03M$19.79M$37.89M$27.59M$22.86M
    Net income-$22.75M-$35.89M-$102.45M-$83.77M-$6.33M-$5.83M$20.95M$51.84M$21.00M$20.52M
    EBITDA-$7.11M-$20.66M-$90.77M-$62.59M$30.16M$12.39M$37.88M$48.49M$41.19M$36.09M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$77.19M$95.08M$85.11M$81.72M$79.09M$92.28M$82.28M$80.08M$88.83M$88.77M$78.03M$75.90M
    Gross profit$34.01M$43.27M$37.86M$35.24M$36.16M$41.34M$36.37M$36.29M$41.34M$42.74M$34.37M$28.16M
    Operating income-$15.58M-$5.10M-$9.34M-$9.31M-$5.43M-$6.13M-$7.66M-$11.39M-$7.79M-$7.06M-$16.27M-$28.98M
    Net income-$16.16M-$3.85M-$8.32M-$7.13M-$5.29M-$4.15M-$6.17M-$9.76M-$5.96M-$5.59M-$14.58M-$26.55M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, cash and equivalents exceeded short-term debt of $3.16M by $100.57M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Total assets$298.63M$296.19M$326.19M$405.04M$489.51M$461.85M$447.34M$375.90M$275.07M$214.05M
    Current assets$224.60M$185.45M$207.07M$304.64M$329.19M$305.70M$292.22M$314.58M$228.49M$161.54M
    Cash and equivalents$103.73M$113.80M$125.49M$187.01M$235.52M$211.96M$198.04M$196.63M$142.95M$92.85M
    Total liabilities$106.39M$122.33M$121.38M$107.64M$119.29M$112.23M$102.72M$65.47M$48.03M$31.96M
    Short-term debt$3.16M$2.81M$3.65M$3.52M$3.39M$1.93M$2.01M$13.07M$11.09M$7.06M
    Shareholder equity$192.23M$173.86M$204.81M$297.41M$370.23M$349.62M$344.62M$310.42M$227.04M$182.09M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$264.91M$285.57M$285.93M$298.63M$307.01M$312.04M$308.41M$296.19M$306.17M$308.92M$315.60M$326.19M
    Total liabilities$107.92M$110.71M$103.02M$106.39M$109.83M$112.55M$110.46M$122.33M$120.77M$121.32M$123.70M$121.38M
    Cash and equivalents$81.84M$87.28M$93.11M$103.73M$106.48M$103.69M$118.89M$113.80M$105.69M$97.92M$107.44M$125.49M
    Shareholder equity$156.99M$174.86M$182.91M$192.23M$197.18M$199.49M$197.95M$173.86M$185.40M$187.59M$191.90M$204.81M
    Last 12 quarters

    Cash Flow

    Operating cash flow was negative in the fiscal year ended Dec 2025.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Operating cash flow-$11.22M$5.91M-$3.23M-$37.53M$23.63M$37.01M$40.59M$59.98M$60.49M$31.03M
    Capital expenditures$2.52M$3.36M$5.22M$3.34M$5.48M$4.38M$3.14M$8.04M$2.91M$1.72M
    Free cash flow-$13.74M$2.55M-$8.45M-$40.87M$18.15M$32.63M$37.45M$51.93M$57.58M$29.32M
    Investing cash flow-$26.21M-$13.97M-$59.31M-$10.88M-$14.64M-$25.64M-$44.06M-$24.96M-$24.43M-$11.93M
    Financing cash flow$24.18M$265.00K$960.00K$380.00K$15.00M$2.07M$4.93M$18.30M$14.00M$7.71M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow-$4.47M$2.95M-$6.68M-$943.00K$2.17M$4.35M-$16.79M-$3.02M$6.99M$6.69M-$4.75M-$3.15M
    Capital expenditures$280.00K$711.00K$210.00K$979.00K$568.00K$684.00K$292.00K$329.00K$1.67M$50.00K$1.31M$1.39M
    Free cash flow-$4.75M$2.23M-$6.89M-$1.92M$1.60M$3.67M-$17.08M-$3.35M$5.32M$6.64M-$6.06M-$4.54M
    Last 12 quarters

    Frequently Asked Questions About INGN

    What is Inogen's annual revenue?

    Inogen reported revenue of $348.67M for the fiscal year ended Dec 31, 2025.

    How fast is Inogen's revenue growing?

    Revenue was up 3.9% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was -2.6%.

    Is Inogen profitable?

    No. Inogen reported net income of -$22.75M for the fiscal year ended Dec 31, 2025, with a net margin of -6.5%.

    How much free cash flow does INGN generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of -$11.22M minus capital expenditures of $2.52M produced free cash flow of -$13.74M.

    How much debt does Inogen have?

    The balance sheet dated Dec 31, 2025 reported short-term debt of $3.16M and cash and equivalents of $103.73M.